Robert M Goodman1, Carolyn B Bridges2, David Kim3, Jamison Pike3, Angela Rose4, Lisa A Prosser4, David W Hutton5. 1. Blue Care Network/Blue Cross Blue Shield of Michigan, Southfield, MI, United States. 2. Centers for Disease Control and Prevention, National Center for Immunization and Respiratory Diseases, Immunization Services Division, Atlanta, GA, United States; Berry Technology Solutions, Inc., Peachtree City, GA, United States(1). 3. Centers for Disease Control and Prevention, National Center for Immunization and Respiratory Diseases, Immunization Services Division, Atlanta, GA, United States. 4. University of Michigan, Ann Arbor, MI, United States. 5. University of Michigan, Ann Arbor, MI, United States. Electronic address: dwhutton@umich.edu.
Abstract
BACKGROUND: Provider concern regarding insurance non-payment for vaccines is a common barrier to provision of adult immunizations. We examined current adult vaccination billing and payment associated with two managed care populations to identify reasons for non-payment of immunization insurance claims. METHODS: We assessed administrative data from 2014 to 2015 from Blue Care Network of Michigan, a nonprofit health maintenance organization, and Blue Cross Complete of Michigan, a Medicaid managed care plan, to determine rates of and reasons for non-payment of adult vaccination claims across patient-care settings, insurance plans, and vaccine types. We compared commercial and Medicaid payment rates to Medicare payment rates and examined patient cost sharing. RESULTS: Pharmacy-submitted claims for adult vaccine doses were almost always paid (commercial 98.5%; Medicaid 100%). As the physician office accounted for the clear majority (79% commercial; 69% Medicaid) of medical (non-pharmacy) vaccination services, we limited further analyses of both commercial and Medicaid medical claims to the physician office setting. In the physician office setting, rates of payment were high with commercial rates of payment (97.9%) greater than Medicaid rates (91.6%). Reasons for non-payment varied, but generally related to the complexity of adult vaccine recommendations (patient diagnosis does not match recommendations) or insurance coverage (complex contracts, multiple insurance payers). Vaccine administration services were also generally paid. Commercial health plan payments were greater for both vaccine dose and vaccine administration than Medicare payments; Medicaid paid a higher amount for the vaccine dose, but less for vaccine administration than Medicare. Patients generally had very low (commercial) or no (Medicaid) cost-sharing for vaccination. CONCLUSIONS: Adult vaccine dose claims were usually paid. Medicaid generally had higher rates of non-payment than commercial insurance.
BACKGROUND: Provider concern regarding insurance non-payment for vaccines is a common barrier to provision of adult immunizations. We examined current adult vaccination billing and payment associated with two managed care populations to identify reasons for non-payment of immunization insurance claims. METHODS: We assessed administrative data from 2014 to 2015 from Blue Care Network of Michigan, a nonprofit health maintenance organization, and Blue Cross Complete of Michigan, a Medicaid managed care plan, to determine rates of and reasons for non-payment of adult vaccination claims across patient-care settings, insurance plans, and vaccine types. We compared commercial and Medicaid payment rates to Medicare payment rates and examined patient cost sharing. RESULTS: Pharmacy-submitted claims for adult vaccine doses were almost always paid (commercial 98.5%; Medicaid 100%). As the physician office accounted for the clear majority (79% commercial; 69% Medicaid) of medical (non-pharmacy) vaccination services, we limited further analyses of both commercial and Medicaid medical claims to the physician office setting. In the physician office setting, rates of payment were high with commercial rates of payment (97.9%) greater than Medicaid rates (91.6%). Reasons for non-payment varied, but generally related to the complexity of adult vaccine recommendations (patient diagnosis does not match recommendations) or insurance coverage (complex contracts, multiple insurance payers). Vaccine administration services were also generally paid. Commercial health plan payments were greater for both vaccine dose and vaccine administration than Medicare payments; Medicaid paid a higher amount for the vaccine dose, but less for vaccine administration than Medicare. Patients generally had very low (commercial) or no (Medicaid) cost-sharing for vaccination. CONCLUSIONS: Adult vaccine dose claims were usually paid. Medicaid generally had higher rates of non-payment than commercial insurance.
Authors: Margaret S Coleman; John Fontanesi; Martin I Meltzer; Abigail Shefer; Daniel B Fishbein; Nancy M Bennett; David Stryker Journal: Vaccine Date: 2005-01-04 Impact factor: 3.641
Authors: Sean T O'Leary; Mandy A Allison; Megan C Lindley; Lori A Crane; Laura P Hurley; Michaela Brtnikova; Brenda L Beaty; Christine I Babbel; Andrea Jimenez-Zambrano; Stephen Berman; Allison Kempe Journal: Pediatrics Date: 2014-02-24 Impact factor: 7.124
Authors: Gary Claxton; Matthew Rae; Nirmita Panchal; Heidi Whitmore; Anthony Damico; Kevin Kenward Journal: Health Aff (Millwood) Date: 2014-09-10 Impact factor: 6.301
Authors: Laura P Hurley; Carolyn B Bridges; Rafael Harpaz; Mandy A Allison; Sean T O'Leary; Lori A Crane; Michaela Brtnikova; Shannon Stokley; Brenda L Beaty; Andrea Jimenez-Zambrano; Faruque Ahmed; Craig Hales; Allison Kempe Journal: Ann Intern Med Date: 2014-02-04 Impact factor: 25.391
Authors: Laura P Hurley; Mandy A Allison; Tamara Pilishvili; Sean T O'Leary; Lori A Crane; Michaela Brtnikova; Brenda L Beaty; Megan C Lindley; Carolyn B Bridges; Allison Kempe Journal: J Am Board Fam Med Date: 2018 Jan-Feb Impact factor: 2.657